IMDA - Indiana Society for Post-Acute Long-Term Care Medicine (IMDA) is a professional association of medical directors and physicians practicing in the long term care continuum dedicated to excellence in patient care.
On this site, IMDA will post original materials along with links to existing resources, tools, articles and legislative information designed to advance our mission to improve patient care and promote the professional development of long term care practitioners. IMDA members are encouraged to submit non-commercial, long term care related items which they feel should be shared with our members.
2014 Indiana Health Care Foundation
AMDA Core Curriculum on Medical Direction in LTC Scholarship
The Indiana Health Care Foundation (IHCF) applauds individuals who are dedicated to advancing their career through continued education. IHCF is accepting scholarship applications from individuals pursing educational training for Medical Director Certification.
Medical Directors who practice in any setting or combination of settings across the long term care continuum,including skilled nursing facilities, assisted living, CCRCs, hospice and home care are encouraged to apply.
Geriatric fellows in training who are considering the inclusion of medical direction in their practices will find this course a beneficial introduction to management requirements for LTC...[CLICK TO READ MORE]
Save the Dates 2014
Click here for upcoming events in 2014.
Two New Links of Interest
January 15, 2014
Physician Orders for Scope of Treatment (POST) - www.iupui.edu/~irespect/POST.html
Indiana State Government website, Bitter Pill - Bitter Pill - www.in.gov/bitterpill/
DEA Issues Statement on Authorized Agents for Schedule III-V Controlled Substances
The Drug Enforcement Administration (DEA) issued a 5-page Statement of Policy on the Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies at http://edocket.access.gpo.gov/2010/pdf/2010-25136.pdf. The DEA Statement provides an example of a written agreement that would confer authority to an agent to act on behalf of an individual practitioner with regard to controlled substance prescriptions. In the Statement, the DEA states "where a DEA-registered individual practitioner has made a valid oral prescription for a controlled substance in Schedules III-V by conveying all the required prescription information to the practitioner's agent, that agent may telephone the pharmacy and convey that prescription information to the pharmacist." This does not apply to Schedule II controlled substances. The Statement adds "An agent may not call in an oral prescription for a Schedule II controlled substance on behalf of a practitioner even in an emergency circumstance."
Individual practitioners may choose to designate and authorize one or more persons at one or more locations within or outside their practice to act as their agent. Likewise, an individual may act as an authorized agent for multiple individual practitioners depending upon the circumstances. A sample agreement designating the agent of practitioner for communicating controlled substance prescriptions to pharmacies is provided in the Statement.
AMDA staff is reviewing the Statement and will publish more details shortly. In addition, AMDA continues to partner with other associations to provide guidance to our respective memberships.
To read the DEA Statement, click here.
Free Resource: Tip Sheet on Controlled Substance Prescribing in LTC
Medical societies seeking to ensure compassionate and high quality care for long term care patients joined together to develop a "Tip Sheet on Prescribing for Controlled Substances in Long Term Care." The document is designed to assist physicians and other prescribers in their efforts to ensure proper controlled substances prescribing in long term care, and deal with aggressive enforcement actions by Drug Enforcement Administration agents. View Tip Sheet